NRx Pharmaceuticals (NASDAQ: NRXP) is making waves in the biotechnology sector today, announcing a monumental milestone in its regulatory journey. It is preparing to submit…
January 20, 2026
A newly emerging cell therapy approach is showing early promise in improving survival outcomes for patients with pancreatic cancer, one of the most aggressive and…
A recent Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) highlights a medical device with the potential to significantly change coronary care…
Boston Scientific (NYSE: BSX) announced an agreement to acquire Penumbra (NYSE: PEN) in a cash-and-stock transaction valued at approximately $14.5 billion in enterprise value. The…
AbbVie (NYSE: ABBV) announced it has entered into a new Most-Favored-Nation (MFN) drug pricing agreement with the U.S. government under recent federal drug pricing reforms….
January 13, 2026
SciSparc Expands MedTech Footprint With Strategic IP Acquisition
SciSparc (NASDAQ: SPRC) announced a definitive agreement to acquire a portfolio of intellectual property assets related to advanced endoscopic systems and medical camera technologies from…
January 13, 2026
Kestra Medical Technologies Announces Strategic Collaboration to Advance Interventional Oncology Innovation
Kestra Medical Technologies (NASDAQ: KMTS) today announced a strategic collaboration with a leading medical technology partner aimed at advancing its interventional oncology product portfolio and…
January 12, 2026
JAZZ & Boehringer Partner to Advance Zanidatamab Strategy
Jazz Pharmaceuticals (NASDAQ: JAZZ) and Boehringer Ingelheim have officially launched a clinical trial collaboration. The partnership focuses on evaluating a new combination therapy for patients…
January 09, 2026
Aktis Oncology Surges in Their Nasdaq Debut
Aktis Oncology (NASDAQ: AKTS) shares surged roughly 50% on Friday after the cancer-focused biotechnology company made its debut on the Nasdaq Global Market, opening at…
January 09, 2026
Autonomix Medical Showcases Strong PoC Data Demonstrating Rapid, Durable Pain Reduction
Autonomix Medical (NASDAQ: AMIX) has released compelling proof-of-concept (PoC) data showing that its nerve-targeted therapy platform delivered rapid and durable pain relief in an initial…
Ceribell (NASDAQ: CBLL) has received Breakthrough Device Designation from the U.S. Food and Drug Administration for its next-generation artificial intelligence-enabled neuromonitoring system, spotlighting the company’s…
January 07, 2026
Jazz Pharma Reports Positive Data for Zanidatamab Combination Therapies in Early Clinical Studies
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced encouraging clinical results showing that combinations involving zanidatamab — its bispecific antibody targeting HER2 — have demonstrated promising activity across…